Cali Biosciences
PrivateLast Round
Series B
Jun 13, 2023
Est. Valuation
$237.32M
Total Funding Raised
$81.94M
Company Overview
Cali Biosciences is a biopharmaceutical company that develops innovative drug delivery platforms and perioperative medications, including anesthesia, analgesia, and anti-inflammatory treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cali Biosciences Comparables
Compare Cali Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRF Technologies Ltd. | 81% | |
| Allay Therapeutics | 81% | |
| Concentric Analgesics | 79% | |
Cali Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2023 | ||||
| Series A | Oct 15, 2021 | ||||
| Early Funding | Jun 4, 2020 |
Key People
Founding team and executive leadership
Cali Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Qianhai Bangqin Investment | Series B |
Cali Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cali Biosciences's valuation, stock price, and market status.